Department of Orthopaedic Surgery, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo 152-8902, Japan.
Department of Orthopaedic Surgery, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan.
J Orthop Sci. 2023 Mar;28(2):446-452. doi: 10.1016/j.jos.2021.11.003. Epub 2021 Dec 11.
In order to improve cancer care in Japan further, it is now required for orthopaedic surgeons to get actively involved in managing locomotive organs such as bones, muscles and nerves in cancer patients. In 2018, the Japanese Orthopaedic Association (JOA) conducted a questionnaire survey to investigate the current status of cancer treatment at the orthopaedic training facilities certified by the JOA. We analyzed the results of that questionnaire survey, focusing on the data from the core hospitals for cancer care (designated cancer hospitals), to clarify the involvement of orthopaedic surgeons in cancer treatment.
A nationwide survey was conducted in the orthopaedic training facilities certified by the JOA using an online questionnaire from March 15th to 31st, 2018. To clarify the involvement of orthopaedic surgeons in cancer treatment, we analyzed the results of that questionnaire survey, focusing on the data from the designated cancer hospitals in Japan.
From the questionnaire survey, it became clear that 24% of the orthopaedic training facilities certified by the JOA are designated cancer hospitals. There were significant differences concerning cancer treatment and the prospect of orthopaedic surgeons' involvement in the treatment for bone metastases between institutions classified according to number of both certified orthopaedic surgeons by the JOA and specialists for bone and soft tissue tumors. In addition, in 45% of the designated cancer hospitals, orthopaedic surgeons treated bone metastases that occur in cancer patients, but in the rest of the institutions, orthopaedic surgeons did not yet adequately respond.
In order to further improve the locomotive function and quality of life (QOL) in cancer patients, it was seemed to be necessary that all medical professionals engaged in cancer treatment, including orthopaedic surgeons, recognize the importance of locomotive management for cancer patients. In addition, the results of this study suggested that the presence of more than six certified orthopaedic surgeons by the JOA, including one or more specialists for bone and soft tissue tumors, may be able to create an environment conducive to the involvement of orthopaedic surgeons in cancer treatment at the facility.
为了进一步提高日本的癌症治疗水平，现在要求骨科医生积极参与管理癌症患者的运动器官，如骨骼、肌肉和神经。2018 年，日本骨科协会（JOA）对通过 JOA 认证的骨科培训设施进行了一项问卷调查，以调查癌症治疗的现状。我们分析了该问卷调查的结果，重点关注癌症治疗核心医院（指定癌症医院）的数据，以明确骨科医生在癌症治疗中的参与情况。
2018 年 3 月 15 日至 31 日，对通过 JOA 认证的骨科培训设施进行了一项全国性的在线问卷调查。为了明确骨科医生在癌症治疗中的参与情况，我们分析了该问卷调查的结果，重点关注日本指定癌症医院的数据。
问卷调查结果表明，JOA 认证的骨科培训设施中有 24%为指定癌症医院。根据 JOA 认证的骨科医生和骨与软组织肿瘤专家的数量对机构进行分类，在癌症治疗和骨科医生参与骨转移治疗的前景方面存在显著差异。此外，在 45%的指定癌症医院，骨科医生治疗癌症患者的骨转移，但在其余机构，骨科医生尚未做出充分响应。
为了进一步提高癌症患者的运动功能和生活质量（QOL），似乎有必要让包括骨科医生在内的所有参与癌症治疗的医疗专业人员认识到对癌症患者运动管理的重要性。此外，本研究结果表明，JOA 认证的骨科医生人数超过 6 人，包括 1 名或多名骨与软组织肿瘤专家，可能有助于在该机构创造有利于骨科医生参与癌症治疗的环境。
